Skip to main content

MoneyWorks4Me

Eiko Lifesciences informs about outcome of board meeting

25 Jan 2024 Evaluate
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Eiko Lifesciences has informed that the Board of Directors in their meeting held today has considered and approved the following: Company (‘ELL') to enter into definitive business agreement with Vivacious Pharmatex (VPPL) for Company’s Growth and strategic positioning. Details as required under listing regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are marked as Annexure-A. The Meeting started at 10:00 AM and concluded at 11:00 AM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Godrej Industries 952.85
SRF 2460.00
BASF India 2935.55
Pidilite Inds. 1583.00
Tata Chemicals 604.75
View more..